Immix Biopharma, Inc.
NASDAQ:IMMX
2.18 (USD) • At close December 24, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -15.596 | -8.23 | -24.384 | -1.148 | -0.973 |
| Depreciation & Amortization
| 0.005 | 0.002 | 0.002 | 0.002 | 0.001 |
| Deferred Income Tax
| 0 | 0 | 22.846 | 0 | 0 |
| Stock Based Compensation
| 2.566 | 0.624 | 0.219 | 0 | 0 |
| Change In Working Capital
| 1.653 | 0.195 | -0.391 | 0.166 | 0.182 |
| Accounts Receivables
| 0 | -0.236 | 0.098 | 0.058 | -0.036 |
| Inventory
| 0 | 0.236 | -0.098 | -0.058 | 0.036 |
| Accounts Payables
| 2.434 | 1.132 | -0.106 | -0.004 | 0.123 |
| Other Working Capital
| -0.782 | -0.937 | -0.285 | 0.17 | 0.059 |
| Other Non Cash Items
| 0 | 0.1 | 0.118 | 0.575 | -0.084 |
| Operating Cash Flow
| -11.371 | -7.408 | -1.589 | -0.405 | -0.79 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -0.052 | 0 | -0.001 | 0 | -0.007 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | -0.001 | 0 | 0 |
| Investing Cash Flow
| -0.052 | 0 | -0.001 | 0 | -0.007 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | 0.2 | 0 | 1.05 |
| Common Stock Issued
| 15.696 | 0 | 18.649 | 0 | 0 |
| Common Stock Repurchased
| 0 | -0.1 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.229 | -0.057 | 0 | 0 | 0 |
| Financing Cash Flow
| 15.464 | 3.232 | 18.849 | 0 | 1.05 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0.033 | -0.032 | -0.005 | 0.062 | 0.019 |
| Net Change In Cash
| 4.073 | -4.208 | 17.253 | -0.343 | 0.272 |
| Cash At End Of Period
| 17.51 | 13.437 | 17.644 | 0.391 | 0.734 |